1
Participants
Start Date
September 30, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Trobalt™
Trobalt™ is a potassium channel opener used as an adjunctive treatment for partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the brain), with or without secondary generalization in adults aged 18 years and above with epilepsy.
Lead Sponsor
GlaxoSmithKline
INDUSTRY